Despite considerable involvement of the spinal cord in amyotrophic lateral sclerosis (ALS),
current biomarker research is primarily centred on brain imaging and CSF proteomics. In …

Background Amyotrophic lateral sclerosis (ALS) is a clinically and histopathologically
heterogeneous neurodegenerative disorder, in which therapy is hindered by the rapid …

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease
characterized by gradual loss of upper and lower motor neurons and their pathways, usually …

Emerging studies corroborate the importance of neuroimaging biomarkers and machine
learning to improve diagnostic classification of amyotrophic lateral sclerosis (ALS). While …

Biomarkers for amyotrophic lateral sclerosis : Current Opinion in Neurology Biomarkers for
amyotrophic lateral sclerosis : Current Opinion in Neurology Log in or Register Subscribe to …

Motor neuron diseases (MNDs) are a debilitating subset of diseases, which result in
progressive neuronal destruction and eventual loss of voluntary muscular function. These …

Amyotrophic lateral sclerosis (ALS) is a complex neurodegenerative disease with clinical,
pathological and genetic overlap with frontotemporal dementia (FTD). No longer viewed as …

ALS research is entering a new phase that should generate new proposals regarding
putative therapies, or strategies for disease treatment. A continuing difficulty, however, is …

Amyotrophic lateral sclerosis (ALS) is associated with considerable clinical heterogeneity
spanning from diverse disability profiles, differences in UMN/LMN involvement, divergent …

Background Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease
characterised by motor neuron degeneration. How this disease affects the central motor …